Loading
Everything in development, the medicines held by this cancer's subtypes, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Oral cavity cancer (mouth and tongue), drawn from the whole corpus: 12 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
3 medicines on record are linked to one of the types below rather than to Oral cavity cancer (mouth and tongue) itself. Grouped by the type that holds them; each list opens that type's own page.
Late presentation remains the norm in the highest-incidence countries.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Symptoms and red flags · Early detection roadmap.
Betel quid use is still rising in parts of Asia.
Field cancerisation causes second primaries in a fifth of survivors.
Speech and swallowing after large resections.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 10 changes by month →When this page itself was last checked or edited.
Median OS 7.
OS 14.
A milestone in how this cancer is treated.
OS 7.
3-year OS 80.